- NeOnc announced poster presentations for intranasal NEO100 (Phase 1/2a) and oral NEO212 (Phase 1) at SNO 2026.
- Presentation focuses on recurrent astrocytoma, TMZ-resistant GBM, and brain metastases.
- Disclosed via Item 7.01; full data will be unveiled at the conference.
Signal #120152 · SEC 8-K
$NTHI SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $NTHI filing catalyst
Why did $NTHI trigger an AI stock catalyst alert?
$NTHI triggered a Stock Catalyst AI alert on 2026-11-03 00:00:00 UTC for a SEC 8-K filing (AI Score: +1.5/10). Headline: NeOnc Technologies to Present NEO100 and NEO212 Data at SNO Meeting. Key points: - NeOnc announced poster presentations for intranasal NEO100 (Phase 1/2a) and oral NEO212 (Phase 1) at SNO 2026. - Presentation focuses on recurrent astrocytoma, TMZ-resistant GBM, and brain metastases. - Disclosed via Item 7.01; full data will be unveiled at the conference.
How did $NTHI stock react after the SEC filing?
After the SEC 8-K for $NTHI, observed market reaction: T0 price $3.07. Past moves do not guarantee future results.
Where can I get real-time $NTHI SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $NTHI via Telegram and the VIP Web Terminal from €10/month.